Therefore, while HNF4G is the dominant transcription factor in primary tumor contexts, a switch occurs in advanced disease, resulting in engagement of FOXA1 to enhancers that create spatial genomic re-organization and ultimately in induction of metastasis-specific gene targets. This evidence concerns the gene HNF4G and neoplasm.